Skip to main content
Erschienen in: Environmental Health and Preventive Medicine 2/2013

01.03.2013 | Regular Article

P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure

verfasst von: Akio Koizumi, Hatasu Kobayashi, Wanyang Liu, Yukiko Fujii, S. T. M. L. D. Senevirathna, Shanika Nanayakkara, Hiroko Okuda, Toshiaki Hitomi, Kouji H. Harada, Katsunobu Takenaka, Takao Watanabe, Shinichiro Shimbo

Erschienen in: Environmental Health and Preventive Medicine | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Background

Moyamoya disease—an idiopathic vascular disorder of intracranial arteries—is often accompanied by hypertension. RNF213 has been identified as a susceptibility gene for moyamoya disease. In the present study, the association of p.R4810K (G>A) with blood pressure (BP) was investigated in a Japanese population.

Methodology/principal findings

Three independent study populations, the Nyukawa (n = 984), Noshiro (n = 2,443) and Field (n = 881) studies, joined this study. BP, body weight and height were measured. Past and present symptoms and disease and medication histories were assessed by interview. Associations of p.R4810K (rs112735431, ss179362673) of RNF213 with BP were investigated. Two linkage disequilibrium blocks were constructed for moyamoya patients with p.R4810K (n = 140) and the general population (n = 384) using 39 single nucleotide polymorphisms (SNPs) spanning 390 kb around RNF213. A total of 60 carriers (3 for AA genotype and 57 for GA genotype) were found in these samples, and the minor allele frequencies were 1.4 % in the Nyukawa and Field studies and 0.2 % in the Noshiro study. Regression analyses adjusted for age, sex and body mass index based on an additive model demonstrated significant associations with systolic BP (mmHg/allele): β (standard error) was 8.2 (2.9) in the Nyukawa study (P = 4.7 × 10−3), 18.7 (5.4) in the Noshiro study (P = 4.6 × 10−4) and 8.9 (2.0) (P = 1.0 × 10−5) in the three populations. In contrast, diastolic BP showed significant associations only in the Noshiro study. Linkage disequilibrium blocks contained none of the BP-associated proxy SNPs reported by previous studies.

Conclusions/significance

Our study suggests that p.R4810K of RNF213 is associated strongly with systolic BP.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Takeuchi K, Shimizu K. Hypogenesis of bilateral internal carotid arteries. Brain Nerve. 1957;9:37–43. Takeuchi K, Shimizu K. Hypogenesis of bilateral internal carotid arteries. Brain Nerve. 1957;9:37–43.
2.
Zurück zum Zitat Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288–99.PubMedCrossRef Suzuki J, Takaku A. Cerebrovascular “moyamoya” disease. Disease showing abnormal net-like vessels in base of brain. Arch Neurol. 1969;20:288–99.PubMedCrossRef
3.
Zurück zum Zitat Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006;77:1025–9.PubMedCrossRef Mineharu Y, Takenaka K, Yamakawa H, Inoue K, Ikeda H, et al. Inheritance pattern of familial moyamoya disease: autosomal dominant mode and genomic imprinting. J Neurol Neurosurg Psychiatry. 2006;77:1025–9.PubMedCrossRef
4.
Zurück zum Zitat Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533–7.PubMedCrossRef Ikeda H, Sasaki T, Yoshimoto T, Fukui M, Arinami T. Mapping of a familial moyamoya disease gene to chromosome 3p24.2-p26. Am J Hum Genet. 1999;64:533–7.PubMedCrossRef
5.
Zurück zum Zitat Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000;15:179–82.PubMedCrossRef Inoue TK, Ikezaki K, Sasazuki T, Matsushima T, Fukui M. Linkage analysis of moyamoya disease on chromosome 6. J Child Neurol. 2000;15:179–82.PubMedCrossRef
6.
Zurück zum Zitat Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004;49:278–81.PubMedCrossRef Sakurai K, Horiuchi Y, Ikeda H, Ikezaki K, Yoshimoto T, et al. A novel susceptibility locus for moyamoya disease on chromosome 8q23. J Hum Genet. 2004;49:278–81.PubMedCrossRef
7.
Zurück zum Zitat Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930–5.PubMedCrossRef Yamauchi T, Tada M, Houkin K, Tanaka T, Nakamura Y, et al. Linkage of familial moyamoya disease (spontaneous occlusion of the circle of Willis) to chromosome 17q25. Stroke. 2000;31:930–5.PubMedCrossRef
8.
Zurück zum Zitat Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008;70:2357–63.PubMedCrossRef Mineharu Y, Liu W, Inoue K, Matsuura N, Inoue S, et al. Autosomal dominant moyamoya disease maps to chromosome 17q25.3. Neurology. 2008;70:2357–63.PubMedCrossRef
9.
Zurück zum Zitat Liu W, Hashikata H, Inoue K, Matsuura N, Mineharu Y, et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med. 2010;15:94–104.PubMedCrossRef Liu W, Hashikata H, Inoue K, Matsuura N, Mineharu Y, et al. A rare Asian founder polymorphism of Raptor may explain the high prevalence of moyamoya disease among East Asians and its low prevalence among Caucasians. Environ Health Prev Med. 2010;15:94–104.PubMedCrossRef
10.
Zurück zum Zitat Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56:34–40.PubMedCrossRef Kamada F, Aoki Y, Narisawa A, Abe Y, Komatsuzaki S, et al. A genome-wide association study identifies RNF213 as the first moyamoya disease gene. J Hum Genet. 2011;56:34–40.PubMedCrossRef
11.
Zurück zum Zitat Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6:e22542.PubMedCrossRef Liu W, Morito D, Takashima S, Mineharu Y, Kobayashi H, et al. Identification of RNF213 as a susceptibility gene for moyamoya disease and its possible role in vascular development. PLoS ONE. 2011;6:e22542.PubMedCrossRef
12.
Zurück zum Zitat Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056–66.PubMedCrossRef Kuroda S, Houkin K. Moyamoya disease: current concepts and future perspectives. Lancet Neurol. 2008;7:1056–66.PubMedCrossRef
13.
Zurück zum Zitat Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with moyamoya disease: angiographic findings. Stroke. 2000;31:733–7.PubMedCrossRef Yamada I, Himeno Y, Matsushima Y, Shibuya H. Renal artery lesions in patients with moyamoya disease: angiographic findings. Stroke. 2000;31:733–7.PubMedCrossRef
14.
Zurück zum Zitat Togao O, Mihara F, Yoshiura T, Tanaka A, Kuwabara Y, et al. Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol. 2004;183:119–22.PubMedCrossRef Togao O, Mihara F, Yoshiura T, Tanaka A, Kuwabara Y, et al. Prevalence of stenoocclusive lesions in the renal and abdominal arteries in moyamoya disease. AJR Am J Roentgenol. 2004;183:119–22.PubMedCrossRef
15.
Zurück zum Zitat Limaye CS, Khude S, Pednekar SJ. Moyamoya disease with hypertension in a young adult. J Assoc Physicians India. 2011;59:124–6.PubMed Limaye CS, Khude S, Pednekar SJ. Moyamoya disease with hypertension in a young adult. J Assoc Physicians India. 2011;59:124–6.PubMed
16.
Zurück zum Zitat Shimbo S, Zhang ZW, Moon CS, Watanabe T, Nakatsuka H, et al. Correlation between urine and blood concentrations, and dietary intake of cadmium and lead among women in the general population of Japan. Int Arch Occup Environ Health. 2000;73:163–70.PubMedCrossRef Shimbo S, Zhang ZW, Moon CS, Watanabe T, Nakatsuka H, et al. Correlation between urine and blood concentrations, and dietary intake of cadmium and lead among women in the general population of Japan. Int Arch Occup Environ Health. 2000;73:163–70.PubMedCrossRef
17.
Zurück zum Zitat Watanabe T, Shimbo S, Nakatsuka H, Koizumi A, Higashikawa K, et al. Gender-related difference, geographical variation and time trend in dietary cadmium intake in Japan. Sci Total Environ. 2004;329:17–27.PubMedCrossRef Watanabe T, Shimbo S, Nakatsuka H, Koizumi A, Higashikawa K, et al. Gender-related difference, geographical variation and time trend in dietary cadmium intake in Japan. Sci Total Environ. 2004;329:17–27.PubMedCrossRef
18.
Zurück zum Zitat Koizumi A, Yoshinaga T, Harada K, Inoue K, Morikawa A, et al. Assessment of human exposure to polychlorinated biphenyls and polybrominated diphenyl ethers in Japan using archived samples from the early 1980s and mid-1990s. Environ Res. 2005;99:31–9.PubMedCrossRef Koizumi A, Yoshinaga T, Harada K, Inoue K, Morikawa A, et al. Assessment of human exposure to polychlorinated biphenyls and polybrominated diphenyl ethers in Japan using archived samples from the early 1980s and mid-1990s. Environ Res. 2005;99:31–9.PubMedCrossRef
19.
Zurück zum Zitat Koizumi A, Harada KH, Inoue K, Hitomi T, Yang HR, et al. Past, present, and future of environmental specimen banks. Environ Health Prev Med. 2009;14:307–18.PubMedCrossRef Koizumi A, Harada KH, Inoue K, Hitomi T, Yang HR, et al. Past, present, and future of environmental specimen banks. Environ Health Prev Med. 2009;14:307–18.PubMedCrossRef
20.
Zurück zum Zitat Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension. 2003;41:207–10.PubMedCrossRef Cui JS, Hopper JL, Harrap SB. Antihypertensive treatments obscure familial contributions to blood pressure variation. Hypertension. 2003;41:207–10.PubMedCrossRef
21.
Zurück zum Zitat Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677–87.PubMedCrossRef Levy D, Ehret GB, Rice K, Verwoert GC, Launer LJ, et al. Genome-wide association study of blood pressure and hypertension. Nat Genet. 2009;41:677–87.PubMedCrossRef
22.
Zurück zum Zitat Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103–9.PubMedCrossRef Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, et al. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103–9.PubMedCrossRef
23.
Zurück zum Zitat Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in East Asians. Nat Genet. 2011;43:531–8.PubMedCrossRef Kato N, Takeuchi F, Tabara Y, Kelly TN, Go MJ, et al. Meta-analysis of genome-wide association studies identifies common variants associated with blood pressure variation in East Asians. Nat Genet. 2011;43:531–8.PubMedCrossRef
24.
Zurück zum Zitat Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amon CI. Shifting paradigm of association studies: value of rare single nucleotide polymorphisms. Am J Human Genet. 2008;82:100–12.CrossRef Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amon CI. Shifting paradigm of association studies: value of rare single nucleotide polymorphisms. Am J Human Genet. 2008;82:100–12.CrossRef
25.
Zurück zum Zitat Slager SL, Huang J, Vieland VJ. Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet Epidemiol. 2000;18:143–56.PubMedCrossRef Slager SL, Huang J, Vieland VJ. Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet Epidemiol. 2000;18:143–56.PubMedCrossRef
26.
Zurück zum Zitat Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149–50.PubMedCrossRef Purcell S, Cherny SS, Sham PC. Genetic power calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149–50.PubMedCrossRef
27.
Zurück zum Zitat Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60–9.PubMedCrossRef Burt VL, Cutler JA, Higgins M, Horan MJ, Labarthe D, et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960 to 1991. Hypertension. 1995;26:60–9.PubMedCrossRef
28.
Zurück zum Zitat Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865–72.PubMedCrossRef Staessen JA, Gasowski J, Wang JG, Thijs L, Den Hond E, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865–72.PubMedCrossRef
29.
Zurück zum Zitat Draheim CC, Geijer JR, Dengel DR. Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome. Am J Cardiol. 2010;106:1512–6.PubMedCrossRef Draheim CC, Geijer JR, Dengel DR. Comparison of intima-media thickness of the carotid artery and cardiovascular disease risk factors in adults with versus without the Down syndrome. Am J Cardiol. 2010;106:1512–6.PubMedCrossRef
30.
Zurück zum Zitat Koduri PR, Agbemadzo B, Nathan S. Hemoglobin S-C disease revisited: clinical study of 106 adults. Am J Hematol. 2001;68:298–300.PubMedCrossRef Koduri PR, Agbemadzo B, Nathan S. Hemoglobin S-C disease revisited: clinical study of 106 adults. Am J Hematol. 2001;68:298–300.PubMedCrossRef
31.
Zurück zum Zitat Reid HL, Anah CO. Haemorheological parameters in hypertensive Nigerians with and without sickle-cell trait. Angiology. 1985;36:379–86.PubMedCrossRef Reid HL, Anah CO. Haemorheological parameters in hypertensive Nigerians with and without sickle-cell trait. Angiology. 1985;36:379–86.PubMedCrossRef
32.
Zurück zum Zitat Zinnamosca L, Petramala L, Cotesta D, Marinelli C, Schina M, et al. Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res. 2011;303:317–25.PubMedCrossRef Zinnamosca L, Petramala L, Cotesta D, Marinelli C, Schina M, et al. Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects. Arch Dermatol Res. 2011;303:317–25.PubMedCrossRef
33.
Zurück zum Zitat Eu-ahsunthornwattana J, Trachoo O, Dejsuphong D, Tunteeratum A, Srichan K, et al. Noonan syndrome, metabolic syndrome and stroke-in-the-young: coincidence, causal or contribution? J Med Assoc Thai. 2010;93:1084–7.PubMed Eu-ahsunthornwattana J, Trachoo O, Dejsuphong D, Tunteeratum A, Srichan K, et al. Noonan syndrome, metabolic syndrome and stroke-in-the-young: coincidence, causal or contribution? J Med Assoc Thai. 2010;93:1084–7.PubMed
34.
Zurück zum Zitat Rokicki W, Rokicka A. Noonan syndrome coexisting with essential arterial hypertension in 8 year old boy. Wiad Lek. 2002;55:488–93.PubMed Rokicki W, Rokicka A. Noonan syndrome coexisting with essential arterial hypertension in 8 year old boy. Wiad Lek. 2002;55:488–93.PubMed
35.
Zurück zum Zitat Di Bartolomeo R, Polidori G, Piastra M, Viola L, Zampino G, et al. Malignant hypertension and cerebral haemorrhage in Seckel syndrome. Eur J Pediatr. 2003;162:860–2.PubMedCrossRef Di Bartolomeo R, Polidori G, Piastra M, Viola L, Zampino G, et al. Malignant hypertension and cerebral haemorrhage in Seckel syndrome. Eur J Pediatr. 2003;162:860–2.PubMedCrossRef
36.
Zurück zum Zitat Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617–27.PubMedCrossRef Guo DC, Papke CL, Tran-Fadulu V, Regalado ES, Avidan N, et al. Mutations in smooth muscle alpha-actin (ACTA2) cause coronary artery disease, stroke, and moyamoya disease, along with thoracic aortic disease. Am J Hum Genet. 2009;84:617–27.PubMedCrossRef
37.
Zurück zum Zitat Miskinyte S, Butler MG, Herve D, Sarret C, Nicolino M, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet. 2011;88:718–28.PubMedCrossRef Miskinyte S, Butler MG, Herve D, Sarret C, Nicolino M, et al. Loss of BRCC3 deubiquitinating enzyme leads to abnormal angiogenesis and is associated with syndromic moyamoya. Am J Hum Genet. 2011;88:718–28.PubMedCrossRef
38.
Zurück zum Zitat Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. 2010;55:1389–97.PubMedCrossRef Giannotti G, Doerries C, Mocharla PS, Mueller MF, Bahlmann FH, et al. Impaired endothelial repair capacity of early endothelial progenitor cells in prehypertension: relation to endothelial dysfunction. Hypertension. 2010;55:1389–97.PubMedCrossRef
Metadaten
Titel
P.R4810K, a polymorphism of RNF213, the susceptibility gene for moyamoya disease, is associated with blood pressure
verfasst von
Akio Koizumi
Hatasu Kobayashi
Wanyang Liu
Yukiko Fujii
S. T. M. L. D. Senevirathna
Shanika Nanayakkara
Hiroko Okuda
Toshiaki Hitomi
Kouji H. Harada
Katsunobu Takenaka
Takao Watanabe
Shinichiro Shimbo
Publikationsdatum
01.03.2013
Verlag
Springer Japan
Erschienen in
Environmental Health and Preventive Medicine / Ausgabe 2/2013
Print ISSN: 1342-078X
Elektronische ISSN: 1347-4715
DOI
https://doi.org/10.1007/s12199-012-0299-1

Weitere Artikel der Ausgabe 2/2013

Environmental Health and Preventive Medicine 2/2013 Zur Ausgabe